Jason Duncan - Jul 22, 2021 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
Chief Legal Officer and GC
Signature
/s/ Jason Duncan
Stock symbol
ALBO
Transactions as of
Jul 22, 2021
Transactions value $
-$10,081
Form type
4
Date filed
7/26/2021, 04:05 PM
Previous filing
Jun 28, 2021
Next filing
Oct 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale -$3.07K -90 -1.13% $34.13 7.89K Jul 22, 2021 Direct F1, F2
transaction ALBO Common Stock Sale -$7.01K -223 -2.83% $31.43 7.67K Jul 23, 2021 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Represents 515 shares of common stock and 7,375 restricted stock units.
F3 Shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
F4 Represents 292 shares of common stock and 7,375 restricted stock units.